Company profile
Augustine Therapeutics company profile
Augustine Therapeutics company is a two drug discovery programs to identify novel generations of selective HDAC6 inhibitors for the treatment of axonopathies such as Charcot Marie Tooth disease. These new compounds have the potential to protect from nerve degeneration and promote peripheral myelin and axon repair.
Business identity
- Website
- https://www.augustinetx.com/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2019-03-01, Month
Headquarters
- Headquarters
- Leuven, Flanders, Belgium
- Postal code
- 3001
- Country code
- BE
- Continent
- Europe